Akrivis Technologies
Ban-An Khaw is the Chief Scientific Officer & Chairman at Akrivis Technologies. Ban-An brings over 40 years of experience and expertise in immunology, immunoassay development, nuclear medicine, nuclear molecular cardiology, and targeted drug delivery.
Ban-An earned an MS and Ph.D. in Biology (Immunology) from Boston College in 1973.
This person is not in any offices
Akrivis Technologies
Akrivis Technologies, LLC is a privately-held biopharmaceutical company founded in 2009 and headquartered in Cambridge, MA. Akrivis is engaged in the early diagnosis and treatment of serious and life-threatening diseases.